30 results on '"Kadija, Zamir"'
Search Results
2. Genetic and geographic influence on phenotypic variation in European sarcoidosis patients
3. Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer
4. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants
5. CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis
6. Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study
7. Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
8. Patients with Alpha-1 antitrypsin Deficiency due to Null mutations have clinical peculiarities and should require personalized pulmonary management
9. In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages
10. Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP).
11. Phenotypes of organ involvement in sarcoidosis
12. The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP)
13. Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP)
14. Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL)
15. Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume?
16. A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant
17. Novel Treatment Options for Autoimmune Pulmonary Alveolar Proteinosis
18. Assessment and management of pulmonary alveolar proteinosis in a reference center
19. Interim Data Analysis Of A Controlled Trial Of Whole Lung Lavage Followed By Inhaled Sargramostin In Autoimmune Pulmonary Alveolar Proteinosis
20. Relationship Between Diffuse Pulmonary Fibrosis, Alveolar Proteinosis, and Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies
21. Familial Interstitial Lung Disease And ABCA3 Gene GLY964ASP Mutation
22. Characteristic Of An Italian Cohort Of Patients With Pulmonary Alveolar ProteINOSis (PAP) And Related Disorders
23. In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages
24. Therapy options in pulmonary alveolar proteinosis
25. The problems of clinical trials and registries in rare diseases
26. Aerosol Characterization of Nebulized GM-CSF
27. Aerosolization Of GM-CSF Using The Akita2 Apixneb Nebulizer Does Not Alter Its Structure Or Function
28. INHALED GMCSF THERAPY IN PULMONARY ALVEOLAR PROTEINOSIS (PAP)
29. Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP)
30. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.